dihexa origin research & Tesofensine Dihexa API | CAS 1401708-83-5

CMS-0057-F (Jan 2026) cuts standard PA timelines to 7 days and urgent to 72 hours

Even your mood might shift, with unexplained depression or irritability

Recently, phase 2 and phase 3 clinical trials on nemolizumab, an anti-IL-31R monoclonal antibody, demonstrated the effectiveness and safety of blocking the IL-31 signaling in treating PN

Strauss, S

Preclinical studies show 60% reduction in gastric lesion size within 24 hours and faster esophageal ulcer closure compared to omeprazole at 14 days in animal models

When comparing different B12 formulations, Sucrosomial B12 has been shown to be more effective than conventional B12 supplements in rapidly and consistently raising blood B12 levels, making it a strong option for treating deficiency